GSK3B and neoplasm: In xenograft models of breast cancer, poly ADP ribose polymerase (PARP) inhibition was shown to upregulate tumor PD-L1 expression via GSK-3β inactivation, suggesting a potential link between not only GSK-3β with immunomodulation but also with DNA damage response modulation [82].